Clinical Trials

290 enrolled

Uterine Cervical Neoplasms

NCT01405586 2023-03-24

MILES-3

299 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01656551 2023-03-24

MILES-4

232 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01802749 2023-03-24

MITO16MANGO2b

406 enrolled

Ovarian Neoplasms

NCT05466318 2022-07-25

ChiCGB vs BEAM in High-risk or R/R Lymphomas

306 enrolled

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04401709 2022-06-15

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

490 enrolled

Biliary Tract Neoplasms

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

420 enrolled

Nasopharyngeal Carcinoma

NCT04617821 2022-01-28

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

300 enrolled

Borderline Resectable Pancreatic Cancer

NCT04679064 2021-08-27

NItCHE-MITO33

427 enrolled

Ovarian Neoplasms

NCT04961970 2021-07-14

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

188 enrolled

Cholangiocarcinoma

NCT04835064 2021-04-08

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

600 enrolled

Pancreatic Adenocarcinoma

NCT04809142 2021-03-22

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer

392 enrolled

Advanced Biliary Cancer

NCT02085655 2021-03-15

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

264 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT04568304 2020-09-29

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

364 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT04167007 2020-08-18

GEMFOX

400 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT04414566 2020-06-04

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

562 enrolled

Nasopharyngeal Carcinoma

NCT01993979 2020-05-04

POUT

261 enrolled

Genitourinary

Transitional Cell Carcinoma of Ureter

NCT03771846 2019-12-05

HAIC Versus Systemic Chemotherapy for Unresectable ICC

188 enrolled

Cholangiocarcinoma

NCT03403829 2019-07-08

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

360 enrolled

Nasopharyngeal Carcinoma

NCT03601975 2019-02-04

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

336 enrolled

Nasopharyngeal Carcinoma

NCT02767674 2019-01-03

Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

258 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03779035 2018-12-19

AdBTC-1

460 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT03623087 2018-08-14

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

68 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT01872962 2018-04-24

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

480 enrolled

Nasopharyngeal Carcinoma

NCT01077427 2017-11-17

HEAT

336 enrolled

Hyperthermia, Pancreatic Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

1,206 enrolled 19 charts

Breast Neoplasms

NCT03006614 2017-01-16

PERS

320 enrolled

Breast Neoplasms

NCT02957266 2016-11-15

CERVIPIB

400 enrolled

Uterine Cervical Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02506842 2016-08-11

Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

300 enrolled

Pancreatic Neoplasms

NCT02798510 2016-06-22

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

140 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02207335 2015-12-22

Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer

120 enrolled

Breast Neoplasms

NCT02548195 2015-09-14

Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

286 enrolled

Cholangiocarcinoma

NCT02355119 2015-02-04

GIP-2

310 enrolled

Pancreatic Neoplasms

NCT01915134 2015-01-01

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

362 enrolled

Nasopharyngeal Carcinoma

NCT02283476 2014-11-06

The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.

200 enrolled

Lung Neoplasms

NCT01586611 2014-10-02

Panc001

175 enrolled

Pancreatic Neoplasms

NCT02074189 2014-02-28

Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer

200 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00003447 2013-12-19

Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

630 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00006048 2013-12-19

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004100 2013-12-18

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02001896 2013-12-05

Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00005869 2013-12-04

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Neoplasms

NCT00005870 2013-12-04

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

Pancreatic Neoplasms

NCT00112710 2013-08-26

Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

1,350 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

800 enrolled

Breast Neoplasms

NCT00440167 2012-07-09

Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

280 enrolled

Pancreatic Neoplasms

NCT01000415 2010-06-24

TGOCphaseIII

824 enrolled

Uterine Cervical Neoplasms

NCT00842660 2010-01-05

Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical Cancer

172 enrolled